Drug trial aims to find new treatment for lupus

Large-Scale Study Large-scale proteomics study reveals subgroups of lupus, paving the way for precision medicine

FDA Awards Breakthrough Status to Second Biologic for CLE

A faster review means there may soon be a novel therapy for the skin manifestations of lupus for the first time in a half-century. Medscape

A revolutionary cancer treatment could transform autoimmune disease

Researchers are testing CAR T cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body

Experimental immune reset treatment puts lupus into remission in early UK trials

Patients on the trial have not needed medication to manage their condition.

Neutrolis Announces New England Journal of Medicine Publication Demonstrating First Clinical Evidence for NET-Degrading Therapy in Severe, Treatment-Refractory Systemic Lupus Erythematosus (SLE) Caused by DNASE1L3 Deficiency

Treatment with investigational DNASE1L3 analog NTR-441, which degrades neutrophil extracellular traps (NETs), resulted in rapid clinical imp

Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment

Conditions : Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus Interventions : Combination Product: Anifrolumab;